Invenomic Capital Management LP Centene Corp Transaction History

Invenomic Capital Management LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	SELL	$61.27 - $70.86 $15.6 Million - $18.1 Million	-255,079 Reduced 41.99%	352,421 $24.3 Million
Q2 2023 Aug 14, 2023	SELL	$61.98 - $69.47 $1.49 Million - $1.67 Million	-24,024 Reduced 3.8%	607,500 $41 Million
Q1 2023 May 15, 2023	BUY	$62.55 - $79.73 $29.7 Million - $37.8 Million	474,372 Added 301.86%	631,524 $39.9 Million
Q4 2022 Feb 14, 2023	BUY	$73.76 - $87.35 $11.6 Million - $13.7 Million	157,152 New	157,152 $12.9 Million
Q4 2021 Feb 11, 2022	SELL	$61.94 - $84.72 $4.14 Million - $5.66 Million	-66,802 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$59.73 - $74.7 $565,583 - $707,334	9,469 Added 16.52%	66,802 $4.16 Million
Q2 2021 Aug 16, 2021	SELL	$59.49 - $74.31 $103,453 - $129,225	-1,739 Reduced 2.94%	57,333 $4.18 Million
Q1 2021 May 13, 2021	BUY	$57.97 - $69.75 $3.42 Million - $4.12 Million	59,072 New	59,072 $3.78 Million

981

445M

2.45M

3.77M

Ticker CNC
Exchange NYSE
Sector Healthcare
Industry Healthcare Plans
Shares Outstandng 566,259,968
Market Cap $33.5B
Description
Centene Corporation operates as a multi-national healthcare enterprise that provides programs and services to under-insured and uninsured individuals in the United States. Its Managed Care segment offers health plan coverage to individuals through government subsidized programs, including Medicaid, the State children's health insurance program, ...

Get notified when there are updates to the investment portfolio of Invenomic Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Invenomic Capital Management LP with notifications on news.